Victoria Prudence Nambasa

8PUBLICATIONS
58CO-AUTHORS
Disease surveillancePharmaceutical delivery technologiesInformation systems for sustainable development and the public goodMajor global burdens of diseaseMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2026
Adverse Events Among People Living With HIV Receiving Dolutegravir-Based Regimens: Findings From a 6-Month Active Pharmacovigilance Study in Uganda.

|Feb 14, 2025
Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda.

Victoria Prudence Nambasa, Anthony Ssebagereka, Agnes Ssali

|Jan 22, 2025
Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.

Victoria Prudence Nambasa, Hannah May Gunter, Modupe Bamidele Adeyemo

|Oct 25, 2024
Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study.

Collins Ankunda, Curthbert Agolor, Yvonne Karamagi

|Nov 27, 2021
Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign-A Case of Measles-Rubella and Polio Vaccines.

Dan Kajungu, Victoria Nambasa, Michael Muhoozi

|Jul 02, 2021
Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda.

Paul Kutyabami, Edson Ireeta Munanura, Rajab Kalidi

Pageof 2

Frequent Collaborators

3 joint publications

Helen Byomire Ndagije

2 joint publications

Beate Kampmann

2 joint publications

Collins Ankunda

2 joint publications

Sharon Namasambi